beta	O
-	O
catenin	O
signaling	O
controls	O
metastasis	O
in	O
Braf	O
-	O
activated	O
Pten	O
-	O
deficient	O
melanomas	B-Cancer
.	O

Malignant	B-Cancer
melanoma	I-Cancer
is	O
characterized	O
by	O
frequent	O
metastasis	O
,	O
however	O
,	O
specific	O
changes	O
that	O
regulate	O
this	O
process	O
have	O
not	O
been	O
clearly	O
delineated	O
.	O

Although	O
it	O
is	O
well	O
known	O
that	O
Wnt	O
signaling	O
is	O
frequently	O
dysregulated	O
in	O
melanoma	B-Cancer
,	O
the	O
functional	O
implications	O
of	O
this	O
observation	O
are	O
unclear	O
.	O

By	O
modulating	O
beta	O
-	O
catenin	O
levels	O
in	O
a	O
mouse	O
model	O
of	O
melanoma	B-Cancer
that	O
is	O
based	O
on	O
melanocyte	B-Cell
-	O
specific	O
Pten	O
loss	O
and	O
Braf	O
(	O
V600E	O
)	O
mutation	O
,	O
we	O
demonstrate	O
that	O
beta	O
-	O
catenin	O
is	O
a	O
central	O
mediator	O
of	O
melanoma	B-Cancer
metastasis	O
to	O
the	O
lymph	B-Multi-tissue_structure
nodes	I-Multi-tissue_structure
and	O
lungs	B-Organ
.	O

In	O
addition	O
to	O
altering	O
metastasis	O
,	O
beta	O
-	O
catenin	O
levels	O
control	O
tumor	B-Cancer
differentiation	O
and	O
regulate	O
both	O
MAPK	O
/	O
Erk	O
and	O
PI3K	O
/	O
Akt	O
signaling	O
.	O

Highly	O
metastatic	B-Cancer
tumors	I-Cancer
with	O
beta	O
-	O
catenin	O
stabilization	O
are	O
very	O
similar	O
to	O
a	O
subset	O
of	O
human	O
melanomas	B-Cancer
.	O

Together	O
these	O
findings	O
establish	O
Wnt	O
signaling	O
as	O
a	O
metastasis	O
regulator	O
in	O
melanoma	B-Cancer
.	O

